Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SILVERNAIL LAUREN P
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-05-17
Sale
2022-05-18
8:21 pm
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
68,204 $12.78 $871,380 141,571
(Direct)
View
2022-03-08
Sale
2022-03-10
7:23 pm
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
10,192 $9.7254 $99,121 209,775
(Direct)
View
2021-08-10
Sale(A)
2021-08-12
7:05 pm
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
14,293 $11.18 $159,774 166,396
(Direct)
View
2021-08-10
Sale
2021-08-12
6:45 pm
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
14,293 $11.18 $159,774 194,982
(Direct)
View
2021-01-25
Sale
2021-01-26
8:51 pm
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
2,699 $7.46 $20,135 90,689
(Direct)
View
2019-05-31
Sale
2019-05-31
7:51 pm
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
2,612 $13.53 $35,352 27,388
(Direct)
View
2018-05-22
Sale
2018-05-24
7:24 pm
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
2,874 $30.25 $86,924 65,497
(Direct)
View
2018-03-22
Sale
2018-03-23
9:12 pm
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
3,431 $30.85 $105,839 68,371
(Direct)
View
2018-03-13
Sale
2018-03-15
8:54 pm
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
25,867 $34.5 $892,412 71,802
(Direct)
View
2018-03-07
Sale
2018-03-09
8:34 pm
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
20,000 $32 $640,000 134,688
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-09-15
Option Award
2022-09-19
4:23 pm
N/A
2032-09-14
Harpoon Therapeutics Inc. HARP SILVERNAIL LAUREN P
Director
20,335 $0 20,335
(Direct)
View
2022-09-15
Ownership
2022-09-19
4:17 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP SILVERNAIL LAUREN P
Director
0 $0 0
(Direct)
View
2022-01-24
Option Award
2022-01-26
9:03 pm
N/A
2032-01-25
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
131,211 $0 297,607
(Direct)
View
2021-01-27
Option Award
2021-02-01
7:29 pm
N/A
N/A
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
90,000 $0 180,689
(Direct)
View
2020-05-13
Option Award
2020-05-15
7:59 pm
N/A
N/A
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
40,000 $0 93,388
(Direct)
View
2020-01-23
Option Award
2020-01-24
9:14 pm
N/A
2030-01-23
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
71,000 $0 98,388
(Direct)
View
2019-01-23
Option Award
2019-01-25
8:21 pm
N/A
2029-01-23
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
45,000 $0 45,000
(Direct)
View
2018-05-29
Option Award
2018-05-31
4:15 pm
N/A
2028-05-29
Evolus Inc. EOLS SILVERNAIL LAUREN P
See Remarks
230,000 $0 230,000
(Direct)
View
2018-03-13
Exercise
2018-03-15
8:54 pm
N/A
N/A
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
25,867 $8.7 71,802
(Direct)
View
2018-03-13
Exercise
2018-03-15
8:54 pm
N/A
2023-05-23
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
25,867 $0 71,802
(Direct)
View
2018-03-13
Tax Withholding
2018-03-15
8:54 pm
N/A
N/A
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
1,152 $31.65 71,802
(Direct)
View
2018-03-07
Exercise
2018-03-09
8:34 pm
N/A
N/A
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
20,000 $8.7 134,688
(Direct)
View
2018-03-07
Exercise
2018-03-09
8:34 pm
N/A
2023-05-23
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
20,000 $0 134,688
(Direct)
View
2018-02-15
Tax Withholding
2018-02-16
7:45 pm
N/A
N/A
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
1,136 $31.75 72,954
(Direct)
View
2018-02-08
Option Award
2018-02-09
9:16 pm
N/A
2028-02-07
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
56,875 $0 122,840
(Direct)
View
2018-01-28
Tax Withholding
2018-01-30
9:06 pm
N/A
N/A
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
990 $33.5 65,965
(Direct)
View
2017-12-29
Other
2018-01-03
8:27 pm
N/A
N/A
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
443 $22.99 67,398
(Direct)
View
2017-12-26
Exercise
2017-12-28
8:51 pm
N/A
N/A
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
17,506 $8.7 112,379
(Direct)
View
2017-12-26
Exercise
2017-12-28
8:51 pm
N/A
2023-05-23
Revance Therapeutics Inc. RVNC SILVERNAIL LAUREN P
CFO
17,506 $0 112,379
(Direct)
View
(A) Indicate amendment filing.